Philipp Ivanyi

2.0k total citations
97 papers, 943 citations indexed

About

Philipp Ivanyi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Philipp Ivanyi has authored 97 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pulmonary and Respiratory Medicine, 50 papers in Oncology and 22 papers in Surgery. Recurrent topics in Philipp Ivanyi's work include Renal cell carcinoma treatment (41 papers), Cancer Immunotherapy and Biomarkers (23 papers) and Renal and related cancers (15 papers). Philipp Ivanyi is often cited by papers focused on Renal cell carcinoma treatment (41 papers), Cancer Immunotherapy and Biomarkers (23 papers) and Renal and related cancers (15 papers). Philipp Ivanyi collaborates with scholars based in Germany, Spain and United States. Philipp Ivanyi's co-authors include Viktor Grünwald, Arnold Ganser, Gernot Beutel, Christoph Reuter, Ralf Gutzmer, Nora Möhn, Thomas Skripuletz, Imke Satzger, Anke Franzke and Hendrik Eggers and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Philipp Ivanyi

78 papers receiving 933 citations

Peers

Philipp Ivanyi

PRM

ONCOL

SURGE

Keita Kudo Japan

Muhammad Khan China

Martha Donoghue United States

Hiroki Ueda Japan

Aurélien Gobert France

Ciara M. Kelly United States

Meredith K. Chuk United States

Yifah Yaron United States

L.L. Siu Canada

Lara Pijuán Spain

Keita Kudo Japan

Philipp Ivanyi

611 ×1.3

PRM

1.0k ×2.4

ONCOL

173 ×0.7

107 ×0.7

122 ×0.9

SURGE

Citations per year, relative to Philipp Ivanyi Philipp Ivanyi (= 1×) peers Keita Kudo

Countries citing papers authored by Philipp Ivanyi

Since Specialization

Citations

This map shows the geographic impact of Philipp Ivanyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Ivanyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Ivanyi more than expected).

Fields of papers citing papers by Philipp Ivanyi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Ivanyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Ivanyi. The network helps show where Philipp Ivanyi may publish in the future.

Co-authorship network of co-authors of Philipp Ivanyi

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Ivanyi. A scholar is included among the top collaborators of Philipp Ivanyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Ivanyi. Philipp Ivanyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Falkenhorst, Johanna, Philipp Ivanyi, Rainer Hamacher, et al.. (2025). Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial). Clinical Cancer Research. 31(19). 4059–4069.

Ivanyi, Philipp, et al.. (2025). Single-Session Surgical Intervention with Resection of a Primary Cranial Osteosarcoma and Cranioplasty using a 3D-Printed Craniotomy Template and Cranioplasty Molds. Journal of Neurological Surgery Reports. 86(1). e8–e13.

Paffenholz, Pia, Jozefina Casuscelli, Emily Rinderknecht, et al.. (2025). Real world evidence from a retrospective multi-center analysis on first-line therapy for metastatic renal cell carcinoma with chromophobe histology.. Journal of Clinical Oncology. 43(5_suppl). 488–488. 1 indexed citations

Darr, Christopher, Jens Bedke, Philipp Ivanyi, et al.. (2025). Treatment of Advanced or Metastatic Urothelial Cancer. Oncology Research and Treatment. 49(1-2). 4–12.

Hammerer, P., Philipp Ivanyi, Marco J. Schnabel, et al.. (2024). P260 Real-world data on treatment patterns and guideline adherence in patients with locally advanced and metastatic urothelial bladder cancer (la/mUC) in Germany. European Urology Open Science. 69. 328–329.

Ivanyi, Philipp, et al.. (2024). Langerhans cell histiocytosis involving the temporal bone with destruction and subsequent reossification of the bony labyrinth boundaries. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 196(10). 1063–1067.

Ivanyi, Philipp, et al.. (2024). The treatment of metastatic renal cell carcinoma. Deutsches Ärzteblatt international. 121(17). 576–586. 2 indexed citations

Paffenholz, Pia, Katrin Schlack, Marco J. Schnabel, et al.. (2024). Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination.. Journal of Clinical Oncology. 42(4_suppl). 436–436.

Möhn, Nora, Lea Grote‐Levi, Tabea Seeliger, et al.. (2023). Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity. Cancer Medicine. 12(8). 9373–9383. 18 indexed citations

10.

Ivanyi, Philipp, et al.. (2023). 358MO Quality-adjusted life-year and life-year estimates for patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the combined positive score 1-19 subgroup treated with pembrolizumab +/- chemotherapy vs cetuximab-containing regimens. Annals of Oncology. 34. S1609–S1609. 1 indexed citations

11.

Ivanyi, Philipp, et al.. (2023). EE359 Cost-Effectiveness of Pembrolizumab + Chemotherapy Versus Cetuximab-Containing Regimens ‘Extreme’ and ‘TPEx’, for R/M SCCHN Patients with a CPS between 1 and 19, in Italy. Value in Health. 26(12). S120–S120.

12.

Eggers, Hendrik, Viktor Grünwald, Linda Rudolph, et al.. (2022). Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?. World Journal of Urology. 40(10). 2489–2497. 5 indexed citations

13.

Möhn, Nora, Kurt‐Wolfram Sühs, Martin Stangel, et al.. (2021). Checkpoint inhibitor–induced autoimmune central nervous system disorder in patients with metastatic melanoma and Hodgkin’s lymphoma. Clinical and Experimental Neuroimmunology. 12(2). 127–134. 1 indexed citations

14.

Möhn, Nora, Ralf Gutzmer, Imke Satzger, et al.. (2020). Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy. Journal of Oncology. 2020. 1–9. 7 indexed citations

15.

Meyer, Bernhard, Jan B. Hinrichs, Philipp Ivanyi, et al.. (2020). Extracorporeal portosystemic shunt in secondary Budd-Chiari syndrome. Journal of Hepatology. 73(4). 974–976. 1 indexed citations

16.

Scheiner, Bernhard, Torsten Voigtländer, Sandra Koch, et al.. (2019). Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. Liver International. 39(4). 714–726. 48 indexed citations

17.

Eggers, Hendrik, M. Krüger, Danny Jonigk, et al.. (2019). Sarcoid-Like Lesions Mimicking Pulmonary Metastasis: A Case Series and Review of the Literature. Oncology Research and Treatment. 42(7-8). 382–386. 2 indexed citations

18.

Grünwald, Viktor, Sebastian Bauer, Bárbara Hermes, et al.. (2019). A randomized phase II study of durvalumab and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma (MEDISARC, AIO-STS 0415).. Journal of Clinical Oncology. 37(15_suppl). TPS11075–TPS11075. 3 indexed citations

19.

Ivanyi, Philipp, Arne Trummer, Jonas Busch, et al.. (2015). Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?. World Journal of Urology. 34(7). 909–915. 5 indexed citations

20.

Ukena, Sya N., Sarvari Velaga, Philipp Ivanyi, et al.. (2011). Isolation strategies of regulatory T cells for clinical trials: Phenotype, function, stability, and expansion capacity. Experimental Hematology. 39(12). 1152–1160. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact